Hasil Pencarian - F. Kaiser

Perbaiki Hasil
  1. 1
    Quartiere kultivieren Quartierbilder : Quartierbilder kultivieren Quartiere

    Quartiere kultivieren Quartierbilder : Quartierbilder kultivieren Quartiere oleh U. Fuhrer, F. Kaiser, M. Marxer

    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Neuromodulation of Foraging Decisions: The Role of Dopamine

    Neuromodulation of Foraging Decisions: The Role of Dopamine oleh Anna Marzecová, Anna Marzecová, Luca F. Kaiser, Armin Maddah

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report

    Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report oleh Vallari Shah, Kevin D. Boyd, Richard S. Houlston, Martin F. Kaiser

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Dosagem laboratorial de enzimas musculares e diagnóstico equivocado de Polimiosite Juvenil: problemas na avaliação clínica e na fase pré-analítica

    Dosagem laboratorial de enzimas musculares e diagnóstico equivocado de Polimiosite Juvenil: problemas na avaliação clínica e na fase pré-analítica oleh Maria Mercedes Picarelli, Glória R.R.F. Kaiser, Carlos Alberto von Mühlen

    Diterbitkan 2004-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Exploiting gene dependency to inform drug development for multiple myeloma

    Exploiting gene dependency to inform drug development for multiple myeloma oleh Molly Went, Phuc H. Hoang, Philip J. Law, Martin F. Kaiser, Richard S. Houlston

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Publisher Correction: Dissociable roles of cortical excitation-inhibition balance during patch-leaving versus value-guided decisions

    Publisher Correction: Dissociable roles of cortical excitation-inhibition balance during patch-leaving versus value-guided decisions oleh Luca F. Kaiser, Theo O. J. Gruendler, Oliver Speck, Lennart Luettgau, Gerhard Jocham

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Dissociable roles of cortical excitation-inhibition balance during patch-leaving versus value-guided decisions

    Dissociable roles of cortical excitation-inhibition balance during patch-leaving versus value-guided decisions oleh Luca F. Kaiser, Theo O. J. Gruendler, Oliver Speck, Lennart Luettgau, Gerhard Jocham

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Improving real‐world myeloma patient access to whole body MRI through “open‐access” knowledge sharing: The UK experience

    Improving real‐world myeloma patient access to whole body MRI through “open‐access” knowledge sharing: The UK experience oleh Martin F Kaiser, Kevin Boyd, Dow‐Mu Koh, Mihaela Rata, Matthew Blackledge, Christina Messiou

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Your Face Mirrors Your Deepest Beliefs—Predicting Personality and Morals through Facial Emotion Recognition

    Your Face Mirrors Your Deepest Beliefs—Predicting Personality and Morals through Facial Emotion Recognition oleh Peter A. Gloor, Andrea Fronzetti Colladon, Erkin Altuntas, Cengiz Cetinkaya, Maximilian F. Kaiser, Lukas Ripperger, Tim Schaefer

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Quantum-limited determination of refractive index difference by means of entanglement

    Quantum-limited determination of refractive index difference by means of entanglement oleh M. Reisner, F. Mazeas, R. Dauliat, B. Leconte, D. Aktas, R. Cannon, P. Roy, R. Jamier, G. Sauder, F. Kaiser, S. Tanzilli, L. Labonté

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients

    Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients oleh Aikaterini Panopoulou, Sandra Easdale, Mark Ethell, Emma Nicholson, Mike Potter, Asterios Giotas, Helena Woods, Tracy Thornton, Charlotte Pawlyn, Kevin D. Boyd, Martin F. Kaiser

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results

    Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results oleh Holger W. Auner, Sarah R. Brown, Katrina Walker, Jessica Kendall, Bryony Dawkins, David Meads, Gareth J. Morgan, Martin F. Kaiser, Mark Cook, Sadie Roberts, Christopher Parrish, Gordon Cook

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.

    A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex. oleh Fabio Mirabella, Alexander Murison, Lauren I Aronson, Christopher P Wardell, Andrew J Thompson, Sarah J Hanrahan, Jacqueline H L Fok, Charlotte Pawlyn, Martin F Kaiser, Brian A Walker, Faith E Davies, Gareth J Morgan

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

    The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients w... oleh Samantha Hinsley, Katrina Walker, Debbie Sherratt, Lucy Bailey, Sadie Reed, Louise Flanagan, Sophie McKee, Fiona Brudenell Straw, Bryony Dawkins, David Meads, Holger W. Auner, Martin F. Kaiser, Mark Cook, Sarah Brown, Gordon Cook, on behalf of the Myeloma UK Clinical Trials Network

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients

    Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients oleh Niels Weinhold, Hans J. Salwender, David A. Cairns, Marc S. Raab, George Waldron, Igor W. Blau, Uta Bertsch, Thomas Hielscher, Gareth J. Morgan, Anna Jauch, Faith E. Davies, Mathias Hänel, Gordon Cook, Christoph Scheid, Richard Houlston, Hartmut Goldschmidt, Graham Jackson, Martin F. Kaiser

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI TrialResearch in context

    Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI... oleh John R. Jones, David A. Cairns, Tom Menzies, Charlotte Pawlyn, Faith E. Davies, Rachel Sigsworth, Annamaria Brioli, Matthew W. Jenner, Martin F. Kaiser, Catherine Olivier, Molly Reed, Mark T. Drayson, Roger G. Owen, Kevin D. Boyd, Gordon Cook, Gareth J. Morgan, Graham H. Jackson

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

    Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus p... oleh G. Sommerhäuser, A. Kurreck, S. Stintzing, V. Heinemann, L. Fischer von Weikersthal, T. Dechow, F. Kaiser, M. Karthaus, I. Schwaner, M. Fuchs, A. König, C. Roderburg, I. Hoyer, M. Quante, A. Kiani, S. Fruehauf, L. Müller, A. Reinacher-Schick, T. J. Ettrich, A. Stahler, D. P. Modest

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUK<i>five</i>)

    Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: res... oleh Kwee L. Yong, Samantha Hinsley, Holger W. Auner, Ceri Bygrave, Martin F. Kaiser, Karthik Ramasamy, Ruth M. de Tute, Debbie Sherratt, Louise Flanagan, Mamta Garg, Stephen Hawkins, Catherine Williams, Jamie Cavenagh, Neil K. Rabin, James Croft, Gareth Morgan, Faith Davies, Roger G. Owen, Sarah R. Brown

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

    Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly di... oleh John R. Jones, Niels Weinhold, Cody Ashby, Brian A. Walker, Chris Wardell, Charlotte Pawlyn, Leo Rasche, Lorenzo Melchor, David A. Cairns, Walter M. Gregory, David Johnson, Dil B. Begum, Sidra Ellis, Amy L. Sherborne, Gordon Cook, Martin F. Kaiser, Mark T. Drayson, Roger G. Owen, Graham H. Jackson, Faith E. Davies, Mel Greaves, Gareth J. Morgan

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3

    Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3 oleh Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. Kaczmarski, Ian Gabriel, Heather E. Oakervee, Martin F. Kaiser, Ashutosh Wechalekar, Reuben Benjamin, Jane F. Apperley, Holger W. Auner, Guido Franzoso

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: